2026-01-18 - Analysis Report
**Company Overview**
Cisco Systems Inc is a multinational technology conglomerate that develops, manufactures, and sells networking hardware and software products.

**Return Comparison**

* Cumulative Return of Review Stock (CSCO): 27.70%
* Cumulative Return of Comparison Stock (VOO): 93.36%
* **Divergence: -65.70** (Relative divergence: 8.40%)
 
**Alpha, Beta Analysis**

| Year       | CAGR  | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|-------|-------|
| 2016-2018  | 17.0% | 19.1% | 14.0% | 1.2 | 171.2B |
| 2017-2019  | 2.0% | 19.1% | -15.0% | 1.3 | 189.5B |
| 2018-2020  | -37.0% | 24.2% | -58.0% | 1.1 | 176.8B |
| 2019-2021  | 1.0% | 24.2% | -42.0% | 1.0 | 250.4B |
| 2020-2022  | -3.0% | 24.7% | -1.0% | 0.9 | 188.2B |
| 2021-2023  | 1.0% | 24.7% | 0.0% | 0.8 | 199.6B |
| 2022-2024  | -20.0% | 22.7% | -40.0% | 0.8 | 233.9B |
| 2023-2025  | 28.0% | 15.3% | -34.0% | 0.8 | 304.4B |

**Recent Stock Price Fluctuations**

* Close: $75.19 
* Last-market Change: -$0.08 
* 5-day SMA: $74.87
* 20-day SMA: $76.18
* 60-day SMA: $75.59

**RSI, PPO, Delta and Expected Return**

* RSI: 31.03
* PPO: -0.23
* Relative divergence change (20 days): +1.30 (+) 
* 7-day Dynamic Expected Return Change: 0 (0) (flat)
* Expected Return: -475.70% (Expected excess return compared to S&P 500) 
* Market Risk Indicator (MRI): 0.80 (Medium Investment Recommended)

**Recent News & Significant Events**

- [2026-01-02] Cisco Systems (CSCO) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
- [2026-01-17] Cisco Systems, Inc. $CSCO Shares Sold by Minneapolis Portfolio Management Group LLC - MarketBeat
- [2026-01-15] Cisco Stock Rises 8% in 3 Months: Will the Rally Continue in 2026? - Zacks Investment Research
- [2026-01-16] Cisco Systems Stock Hands $144 Bil Back – Worth a Look? - Trefis
- [2026-01-16] Cisco stock price edges up as CSCO sets Feb. 3 AI Summit with Nvidia’s Huang and OpenAI’s Altman - TechStock²
- [2026-01-13] Cisco Systems Stock (CSCO) Opinions on AI Deals and Legal Challenges - Quiver Quantitative

**Analyst Opinions**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.96 (~Buy)
  - Opinions: 21
  - Target Price (avg/high/low): $86.00 / $100.00 / $67.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|-------|-------|
| 2025-11-18 | $0.72 | $14.88 B |
| 2025-05-20 | $0.63 | $14.15 B |
| 2025-02-18 | $0.61 | $13.99 B |
| 2024-11-19 | $0.68 | $13.84 B |
| 2025-11-18 | $0.68 | $13.84 B |

The recent earning shows a decrease in EPS in Q2 2025 ($0.63) and Q3 2025 ($0.61) and a slight increase in EPS ($0.72) and revenue ($14.88 B) in Q4 2025.

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $14.88B | 65.48% |
| 2025-07-31 | $14.67B | 63.25% |
| 2025-04-30 | $14.15B | 65.57% |
| 2025-01-31 | $13.99B | 65.12% |
| 2024-10-31 | $13.84B | 65.90% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $46.87B | 6.10% |
| 2025-07-31 | $46.84B | 5.44% |
| 2025-04-30 | $45.94B | 5.42% |
| 2025-01-31 | $45.53B | 5.33% |
| 2024-10-31 | $45.28B | 5.99% |

The revenue shows a slight increase in Q3 2025 ($14.67B) compared to Q2 2025 ($14.15B). The profit margin remains relatively stable.

**Comprehensive Analysis (Summary)**

Cisco Systems Inc has shown a cumulative return of 27.70% compared to S&P 500's 93.36%. The stock has had a significant fluctuation in price over the years with a current price of $75.19 and moving average prices of $74.87 and $76.18 for 5 and 20-day periods respectively. The relative divergence change is +1.30, showing an improving signal over the last 20 days. The stock has a market risk indicator of 0.80, indicating a medium investment strategy.

The earnings results over the last year have been mixed with a slight increase in Q4 2025 ($0.72) and EPS ($0.63, $0.61) in the previous periods. The revenue showed a slight increase in Q3 2025 ($14.67B) compared to Q2 2025 ($14.15B).

Overall, the stock has shown a decrease in expected return (-475.70%) compared to the S&P 500, indicating a high level of risk. However, the recent news and events suggest a positive trend with an improving relative divergence signal and increasing revenue.

**Key Points to Consider**

* Cumulative return difference: -65.70
* Market Risk Indicator: 0.80 (Medium Investment Recommended)
* Relative divergence change: +1.30 (+) 
* 7-day Dynamic Expected Return Change: 0 (0) (flat)
* Expected Return: -475.70% (Expected excess return compared to S&P 500)
* Analyst Consensus: Buy
* Target Price (avg/high/low): $86.00 / $100.00 / $67.00
* Recent earnings analysis suggests a decrease in EPS in Q2 and Q3 but slight increase in Q4.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.